TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Clinical trial NCT04887506 · COMPLETED

Trial details

NCT number: NCT04887506
Sponsor: Tavanta Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Metastatic Castration-sensitive Prostate Cancer Metastatic Prostate Cancer

Start date: 2021-05-05
Primary completion: 2022-10-20
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.